These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7779607

  • 1. DNA topoisomerase inhibitors.
    Capranico G, Giaccone G, Zunino F, Garattini S, D'Incalci M.
    Cancer Chemother Biol Response Modif; 1994; 15():67-86. PubMed ID: 7779607
    [No Abstract] [Full Text] [Related]

  • 2. [DNA topoisomerases targeting anticancer agents and mechanism for acquirement of drug resistance].
    Furukawa M, Harada T, Tanaka T, Kuwano M.
    Nihon Rinsho; 1997 May; 55(5):1096-102. PubMed ID: 9155159
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.
    Ellis AL, Nowak B, Plunkett W, Zwelling LA.
    Cancer Chemother Pharmacol; 1994 May; 34(3):249-56. PubMed ID: 8004759
    [Abstract] [Full Text] [Related]

  • 5. Yeast as a genetic model system for studying topoisomerase inhibitors.
    Nitiss JL.
    Adv Pharmacol; 1994 May; 29B():201-26. PubMed ID: 8996609
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Therapeutic approach for colorectal cancer with topoisomerase as a molecular target].
    Tsunoda T.
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():472-5. PubMed ID: 14574938
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Topoisomerase inhibitors. A review of their therapeutic potential in cancer.
    Sinha BK.
    Drugs; 1995 Jan; 49(1):11-9. PubMed ID: 7705211
    [Abstract] [Full Text] [Related]

  • 11. DNA topoisomerase inhibitors as antifungal agents.
    Shen LL, Fostel JM.
    Adv Pharmacol; 1994 Jan; 29B():227-44. PubMed ID: 8996610
    [No Abstract] [Full Text] [Related]

  • 12. Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines.
    Keshelava N, Groshen S, Reynolds CP.
    Cancer Chemother Pharmacol; 2000 Jan; 45(1):1-8. PubMed ID: 10647494
    [Abstract] [Full Text] [Related]

  • 13. DNA topoisomerase I poisons.
    Takimoto CH, Kieffer LV, Kieffer ME, Arbuck SG, Wright J.
    Cancer Chemother Biol Response Modif; 1999 Jan; 18():81-124. PubMed ID: 10800479
    [No Abstract] [Full Text] [Related]

  • 14. The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase.
    Musk SR, Steel GG.
    Br J Cancer; 1990 Sep; 62(3):364-7. PubMed ID: 2169851
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning.
    Saleem A, Ibrahim N, Patel M, Li XG, Gupta E, Mendoza J, Pantazis P, Rubin EH.
    Cancer Res; 1997 Nov 15; 57(22):5100-6. PubMed ID: 9371509
    [Abstract] [Full Text] [Related]

  • 16. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
    Wong ML, Hsu MT.
    J Virol; 1990 Feb 15; 64(2):691-9. PubMed ID: 2153235
    [Abstract] [Full Text] [Related]

  • 17. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
    Ling YH, Andersson BS, Nelson JA.
    Cancer Biochem Biophys; 1990 Jan 15; 11(1):23-30. PubMed ID: 2159843
    [Abstract] [Full Text] [Related]

  • 18. Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.
    Levac P, Moss T.
    Chromosoma; 1996 Oct 15; 105(4):250-60. PubMed ID: 8854885
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of resistance to drugs that inhibit DNA topoisomerases.
    Beck WT, Danks MK.
    Semin Cancer Biol; 1991 Aug 15; 2(4):235-44. PubMed ID: 1655118
    [Abstract] [Full Text] [Related]

  • 20. Antiproliferative activity of the topoisomerase I inhibitors topotecan and camptothecin, on sub- and postconfluent tumor cell cultures.
    Pizao PE, Smitskamp-Wilms E, Van Ark-Otte J, Beijnen JH, Peters GJ, Pinedo HM, Giaccone G.
    Biochem Pharmacol; 1994 Sep 15; 48(6):1145-54. PubMed ID: 7945408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.